Healthcare Stocks 2026

Healthcare combines defensive characteristics with secular growth — aging demographics in developed markets, rising drug-spend per capita, and a pipeline-driven innovation cycle in biotech and medical devices. Big Pharma trades at lower multiples but offers steady dividends and patent-protected cash flows; biotech rewards binary catalyst-pickers. Watch for payer pressure on US drug pricing and FDA decisions that re-rate single names overnight.